Effect of DL-2(p-aminophenyl)-2-phenylethylamine on adrenocortical function in Cushing's syndrome due to nontumorous adrenocrotical hyperfunction.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000311:Adrenal Glands / Q000187:drug effects*; D000308:Adrenocortical Hyperfunction / Q000188:drug therapy*; D000328:Adult; D003480:Cushing Syndrome / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D010627:Phenethylamines / Q000494:pharmacology*; D013739:Testosterone / Q000652:urine
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D010627:Phenethylamines; D013739:Testosterone